The world’s first commercial gene-editing treatment is set to start changing the lives of people…
karnottDecember 12, 2023
A four-year-old Boston startup is getting $90 million to help develop radioactive molecules that target…
karnottDecember 11, 2023
Vital pulp therapy and root canal therapy (RCT) are the dominant treatment for irreversible pulpitis.…
karnottDecember 11, 2023
Adding an immunotherapy agent to the standard therapy for HER2+ metastatic breast cancer can significantly…
karnottDecember 11, 2023
Each gene in the human genome has two copies. When researchers detect two mutations within…
karnottDecember 8, 2023
Spinal muscular atrophy (SMA) is caused by mutations in SMN1. SMN2 is a paralogous gene…
karnottDecember 7, 2023
Cytokines mediate cell–cell communication in the immune system and represent important therapeutic targets. A myriad…
karnottDecember 7, 2023
The BRI Research Excellence Awards, which promote the research of promising BWH junior investigators and…
karnottDecember 7, 2023
The “in silico–in vitro–in vivo” funnel holds significant potential for identifying targets to control cellular…
karnottNovember 28, 2023
